| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |